Literature DB >> 7747762

Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions.

G Scirè1, B Dallapiccola, P Iannetti, F Bonaiuto, C Galasso, R Mingarelli, B Boscherini.   

Abstract

We report on two adolescents with 22q11 deletion. Their main clinical manifestation was chronic symptomatic hypocalcemia secondary to hypoparathyroidism, together with seizures and cerebral calcifications. Neither congenital cardiac abnormality nor T cell deficiency were detected. The phenotypic manifestations of the observed patients were consistent with velo-cardio-facial syndrome (VCFS). A microdeletion of chromosome region 22q11 has been demonstrated in approximately 90% of DiGeorge syndrome (DGS) patients and in 75% of VCFS patients; the association of the deletion with a wide spectrum of clinical findings suggests the existence of a contiguous gene syndrome. The presence of certain traits of DGS/VCFS should lead to investigations of the parathyroid function and molecular analysis of the 22q11 region hybridization studies.

Entities:  

Mesh:

Year:  1994        PMID: 7747762     DOI: 10.1002/ajmg.1320520415

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

1.  Prevalence of 22q11 microdeletion.

Authors:  S Tézenas Du Montcel; H Mendizabai; S Aymé; A Lévy; N Philip
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

2.  Idiopathic hypoparathyroidism in two patients with 22q11 microdeletion.

Authors:  Y Makita; M Masuno; K Maizumi; K Tachibana; Y Kuroki; H Kurahashi
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

3.  Monozygotic twins with chromosome 22q11 deletion and discordant phenotype.

Authors:  J Goodship; I Cross; P Scambler; J Burn
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

Review 4.  Phenotype of adults with the 22q11 deletion syndrome: A review.

Authors:  E Cohen; E W Chow; R Weksberg; A S Bassett
Journal:  Am J Med Genet       Date:  1999-10-08

5.  Sarcoidosis presenting with severe hypocalcaemia.

Authors:  A Saeed; M Khan; S Irwin; A Fraser
Journal:  Ir J Med Sci       Date:  2009-01-31       Impact factor: 1.568

6.  A Hirschsprung disease locus at 22q11?

Authors:  W S Kerstjens-Frederikse; R M Hofstra; A J van Essen; J H Meijers; C H Buys
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

7.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

8.  A patient with 22q11.2 deletion syndrome: case report.

Authors:  Sema Kabataş Eryılmaz; Firdevs Baş; Ali Satan; Feyza Darendeliler; Rüveyde Bundak; Hülya Günöz; Nurçin Saka
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-02-06

9.  Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome).

Authors:  Mc Digilio; B Marino; R Capolino; B Dallapiccola
Journal:  Images Paediatr Cardiol       Date:  2005-04

10.  Seizures as the first manifestation of chromosome 22q11.2 deletion syndrome in a 40-year old man: a case report.

Authors:  Adriano R Tonelli; Kalyan Kosuri; Sainan Wei; Davoren Chick
Journal:  J Med Case Rep       Date:  2007-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.